This survey shows that three-quarters think it is acceptable for public health officials to make personal information that may be collected during the coronavirus outbreak available for use by infectious disease researchers, while smaller shares say the same about pharmaceutical companies (40%), health insurance companies (40%) and state and local elected officials (37%).